Understanding brain changes in youth at risk for psychosis
Part of Mental health clinical trials.
This research study looks at how the brain changes in young people who are at high risk for developing psychosis. It aims to find better ways to predict and prevent psychosis by using brain imaging and thinking tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 35 years old.
- You can understand and sign a consent form (or have a parent sign for you if under 18).
- You have not had alcohol or drug dependence in the past 3 months, and you are not intoxicated today.
- You have early warning signs of psychosis (like mild unusual thoughts or perceptions) that started or worsened in the last year.
- You have never been diagnosed with a full psychotic disorder (like schizophrenia).
- You do not have a serious brain injury or an intellectual disability (IQ below 70).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a type of magnetic brain stimulation (rTMS) can help people who are at high risk for psychosis. The stimulation is personalized using a brain scan called magnetoencephalography (MEG) to target the right areas.
This trial tests how the brain’s cell membranes and energy use look in teens who are at high risk of developing psychosis. It compares them with healthy teens to better understand early brain changes that might help future care.
This study tests whether a type of brain training called neurofeedback can help young people who are at high risk for developing psychosis. The training is designed to help the brain work better and may reduce symptoms.
This study looks at brain scans and other health information to understand mental health conditions better. You may be able to join if you are a young adult or teen with early signs of mental health changes.
This trial tests a type of therapy called Mentalization Based Treatment (MBT) for young people who are at high risk for developing psychosis. The therapy helps you understand your own and others' thoughts and feelings, with the goal of reducing distress and preventing psychosis.
This study uses brain scans and a medication called methylphenidate (Ritalin) to understand how the brain chemical dopamine works in people at early risk for psychosis. It may help researchers find better ways to predict and treat psychosis.
Hear when a new Psychosis; Schizophrenia-Like trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.